Clinical Trial Update: Evaluating Preventive Therapy With Oint Threolone, Synthomycine or Aqua Cream, for EGFR'I Induced Acneiform Rash [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating preventive therapies (Oint Threolone, Synthomycine, and Aqua Cream) for EGFR inhibitor–induced acneiform rash has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acneiform Rash

Drugs mentioned

• Aqua Cream
• Oint Threolone
• Synthomycine

Snippet

Sponsor: Rabin Medical Center | Conditions: Acneiform Rash | Phase 2 | Status: COMPLETED